http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103298805-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9522e625f762330fe22dfe11685f76
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1045cf6c9275697db4891f1ad124f056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6823960c8a0e818e40b2fac650179b18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1905bce594539d418d22d584ae51d0d
publicationDate 2013-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103298805-A
titleOfInvention Quinazoline compounds and methods of use thereof
abstract The present invention provides quinazoline compounds of formula (I) for treating JAK kinase-mediated diseases (including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases). Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105503837-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105503837-B
priorityDate 2010-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010038060-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005038023-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010099379-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56848694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421146793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56848564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421146806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163815641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66613420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465522157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421146750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56848754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421146770

Total number of triples: 48.